TNF and type 2 diabetes mellitus: A shift in balance from an immunometabolic adaptive profile, observed in healthy muscle tissue, to a maladaptive state as observed in chronic metabolic disorders (obesity, Ray, Mahata, & De, 2016 and T2DM), occurs through deficient cross‐talk between immune and metabolic signaling factors such as the inflammasome (Próchnicki & Latz, 2017), insulin receptors (Hotamisligil, 2017b), TNFα (Austin, Rune, Bouzakri, Zierath, & Krook, 2008; Hotamisligil, Shargill, & Spiegelman, 1993), and other cytokines (Fink, Oberbach, Costford, et al., 2013; Pillon & Krook, 2017).